Abstract:
The present invention provides methods for classifying subjects exposed to viral infection, in particular influenza. The methods may be used to classify subjects before they show symptoms of infection. The methods may also be used to classify subjects who are infected but are asymptomatic. The present invention also provides an apparatus for performing the methods of the invention as well as related methods for controlling the spread of viral infections and/or secondary bacterial infections.
Abstract:
Methods of predicting hepatotoxicity of a compound by providing an in vitro hepatocyte culture system capable of expressing a panel of genes, wherein the culture may be incubated with the compound or compounds to be screened and the expression level of the panel of genes measured is described herein. By comparing the expression level of the panel of genes in the culture system exposed to the compound(s) being screened with the gene expression of the same panel of genes in a control culture system, hepatotoxicity of the compound(s) is able to be predicted.
Abstract:
The present invention relates to methods of treating and diagnosing oxidative damage in a subject comprising administering an agent that binds oxidized extracellular nucleic acid, and methods of treating diseases and conditions in a subject comprising administering an adjuvant therapy comprising an agent that binds oxidized extracellular nucleic acid. The oxidized fraction of extracellular DNA can also be detected through electrochemical methods or by mass- spectrometry.
Abstract:
A novel method to predict toxicity and dose-dependent effects of an agent based on transcriptomic data analysis, by determining a predictive toxicogenomics space (PTGS) score. The PTGS score helps to predict and model the toxicity of compounds typically consisting of chemicals, pharmaceuticals, cosmetics and agrochemicals. The invention further comprises methods of deriving the PTGS score, as well as computer programs to calculate PTGS scores.
Abstract:
The invention provides epsilon toxin (ETX) produced by Clostridium perfringens type B or type D as a causative toxin for human multiple sclerosis (MS). The invention further identifies ETX binding receptor MAL for ETX mediated cell death and other toxin- logical activities in MS. Methods and compositions to prevent humans from multiple sclerosis (MS) and/or treating MS by directly or indirectly interfering with epsilon toxin (ETX), its binding receptor (e.g., MAL), or ETX-receptor interactions so as to inhibit or suppress downstream ETX mediated receptor signaling activities are provided. Also provided are various methods to detect, diagnose, monitor, assess multiple sclerosis (MS) by determining an expression level of ETX gene or its encoding protein in human patient suspected for and/or at risk for multiple sclerosis (MS).
Abstract:
본 발명은 카드뮴 노출 여부 확인용 마이크로어레이 칩 및 이를 이용하여 카드뮴 노출 여부를 확인하는 방법을 제공한다. 본 발명의 카드뮴 노출 여부 확인용 마이크로어레이 칩은 카드뮴 노출 여부 모니터링 및 위해성 판정에 유용하게 이용될 수 있으며, 아울러 카드뮴에 의해 야기되는 독성 작용 기작을 규명하는 도구로 활용될 수 있다.
Abstract:
본 발명은 니켈 노출 여부 확인용 마이크로어레이 칩 및 이를 이용하여 니켈 노출 여부를 확인하는 방법을 제공한다. 본 발명의 니켈 노출 여부 확인용 마이크로어레이 칩은 니켈 노출 여부 모니터링 및 위해성 판정에 유용하게 이용될 수 있으며, 아울러 니켈에 의해 야기되는 독성 작용 기작을 규명하는 도구로 활용될 수 있다.
Abstract:
본 발명은 서열번호 1의 염기서열로 이루어진 예쁜꼬마선충 ( Caenorhabditis elegans ) 유래 mtl-2 ( metallothionein-2 ) 유전자를 포함하는 광산 토양 중의 중금속 검출용 키트, 중금속으로 오염된 것으로 추정되는 광산 토양 시료에 노출시킨 예쁜꼬마선충으로부터 mtl-2 유전자의 발현 수준을 측정하는 단계를 포함하는 광산 토양 중의 중금속의 존재 여부를 검출하는 방법 및 예쁜꼬마선충 유래 mtl-2 유전자를 포함하는 광산 토양 중의 중금속 검출용 조성물을 제공한다.
Abstract:
A method for determining toxicity of a sample, particularly a soil sample suspected of containing polycyclic aromatic hydrocarbon pollutants, is provided. The method allows for quantification of toxicity levels based on gene expression profiling of a test organism, for example Folsomia candida,exposed to the sample.
Abstract:
The present invention provides methods for conducting screens using nucleic acid elements (e.g., interfering RNAs) to confidently identify hit genetic elements. The present invention further comprises constructing vectors that contain two or more nucleic acid elements to knock down all pairwise combinations of the hit genetic elements identified from the screen. Following quantitation of the single and double-knockdown phenotypes, genetic interactions between all gene pairs can be calculated. Genes can then be clustered according to the similarity of the pattern of their interactions with all of the other genes to obtain a genetic interaction map, which can advantageously be used to predict functional associations between genes and identify drug targets for therapy such as combination cancer therapy.